The One Health approach recognizes the interconnectedness of human, animal, and environmental health, emphasizing that diseases often emerge at the interface of these systems. It promotes cross-sector collaboration among physicians, veterinarians, ecologists, and public health professionals to prevent, detect, and control infectious diseases, including zoonoses like influenza, COVID-19, and rabies. Beyond disease prevention, One Health also addresses antimicrobial resistance, food safety, and climate-related health risks, making it a holistic strategy for global health security.
Market Analysis: In 2025, the global One Health market—including surveillance systems, diagnostics, vaccines, and collaborative research programs—is valued at around USD 12.4 billion. With increasing investments in zoonotic disease control, AMR monitoring, and integrated health programs, the market is projected to reach USD 21.7 billion by 2030, growing at a CAGR of 11.5%. North America and Europe dominate due to strong intersectoral policies, while Asia-Pacific and Africa are emerging as key growth regions, driven by high zoonotic disease burden and international funding support.
